BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9839310)

  • 21. Risk factors for the development of post-transplant lymphoproliferative disorder in a large animal model.
    Cho PS; Mueller NJ; Cameron AM; Cina RA; Coburn RC; Hettiaratchy S; Melendy E; Neville DM; Patience C; Fishman JA; Sachs DH; Huang CA
    Am J Transplant; 2004 Aug; 4(8):1274-82. PubMed ID: 15268728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Posttransplantation lymphoproliferative disorder: changing manifestations of disease in a renal transplant population.
    Miller WT; Siegel SG; Montone KT
    Crit Rev Diagn Imaging; 1997 Dec; 38(6):569-85. PubMed ID: 9442979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary Ki-1 (anaplastic large cell) lymphoma of the brain and spinal cord.
    Havlioglu N; Manepalli A; Galindo L; Sotelo-Avila C; Grosso L
    Am J Clin Pathol; 1995 Apr; 103(4):496-9. PubMed ID: 7726150
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients.
    Younes BS; McDiarmid SV; Martin MG; Vargas JH; Goss JA; Busuttil RW; Ament ME
    Transplantation; 2000 Jul; 70(1):94-9. PubMed ID: 10919581
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cutaneous lymphoproliferative disorders in organ transplant recipients: update 2014.
    Seçkin D
    G Ital Dermatol Venereol; 2014 Aug; 149(4):401-8. PubMed ID: 25068227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Key features distinguishing post-transplantation lymphoproliferative disorders and acute liver rejection.
    Rizkalla KS; Asfar SK; McLean CA; Garcia BM; Wall WJ; Grant DR
    Mod Pathol; 1997 Jul; 10(7):708-15. PubMed ID: 9237182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-transplantation lymphoproliferative disorder of the NK-cell type: a case report and review of the literature.
    Hsi ED; Picken MM; Alkan S
    Mod Pathol; 1998 May; 11(5):479-84. PubMed ID: 9619602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Posttransplant lymphoproliferative disorder in adult liver transplant recipients: a report of seventeen cases.
    Patel H; Vogl DT; Aqui N; Shaked A; Olthoff K; Markmann J; Reddy R; Stadtmauer EA; Schuster S; Tsai DE
    Leuk Lymphoma; 2007 May; 48(5):885-91. PubMed ID: 17487731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An immunohistochemical analysis of Reed-Sternberg-like cells in posttransplantation lymphoproliferative disorders: the possible pathogenetic relationship to Reed-Sternberg cells in Hodgkin's disease and Reed-Sternberg-like cells in non-Hodgkin's lymphomas and reactive conditions.
    Chetty R; Biddolph S; Gatter K
    Hum Pathol; 1997 Apr; 28(4):493-8. PubMed ID: 9104951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T-cell posttransplant lymphoproliferative disorder occurring in a pediatric solid-organ transplant patient.
    Lundell R; Elenitoba-Johnson KS; Lim MS
    Am J Surg Pathol; 2004 Jul; 28(7):967-73. PubMed ID: 15223970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-transplantation lymphoproliferative disorder of recipient origin in a boy with acute T-cell leukemia with detection of B-cell clonality 3 months before stem cell transplantation.
    Kontny U; Boppana S; Jung A; Goebel H; Strahm B; Peters A; Dormann S; Werner M; Bader P; Fisch P; Niemeyer C
    Haematologica; 2005 Nov; 90 Suppl():ECR27. PubMed ID: 16266918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
    Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-transplant lymphoproliferative disorder after liver transplantation: Incidence, long-term survival and impact of serum tacrolimus level.
    Eshraghian A; Imanieh MH; Dehghani SM; Nikeghbalian S; Shamsaeefar A; Barshans F; Kazemi K; Geramizadeh B; Malek-Hosseini SA
    World J Gastroenterol; 2017 Feb; 23(7):1224-1232. PubMed ID: 28275302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of radiation therapy in posttransplant lymphoproliferative disorder (PTLD) after liver transplantation.
    Koffman BH; Kennedy AS; Heyman M; Colonna J; Howell C
    Int J Cancer; 2000 Apr; 90(2):104-9. PubMed ID: 10814960
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-transplantation lymphoproliferative disorder after liver transplantation: report of 5 cases among more than 550 liver transplants in Iran.
    Geramizadeh B; Malek-Hosseini SA; Bahador A; Salahi H; Nikeghbalian S; Sharifian M; Lankarani KB; Imanieh MH; Dehghani M
    Arch Iran Med; 2010 Sep; 13(5):417-9. PubMed ID: 20804309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Posttransplant lymphoproliferative disorder in pediatric renal transplantation.
    Srivastava T; Zwick DL; Rothberg PG; Warady BA
    Pediatr Nephrol; 1999 Nov; 13(9):748-54. PubMed ID: 10603113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EBV-associated B- and T-cell posttransplant lymphoproliferative disorders following primary EBV infection in a kidney transplant recipient.
    Yin CC; Medeiros LJ; Abruzzo LV; Jones D; Farhood AI; Thomazy VA
    Am J Clin Pathol; 2005 Feb; 123(2):222-8. PubMed ID: 15842046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased survival in hepatitis C patients with monomorphic post-transplant lymphoproliferative disorder after liver transplantation treated with frontline immunochemotherapy.
    Alderuccio JP; Stefanovic A; Dammrich D; Chapman JR; Vega F; Selvaggi G; Tzakis A; Lossos IS
    Leuk Lymphoma; 2018 Sep; 59(9):2096-2104. PubMed ID: 29252057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy.
    Darenkov IA; Marcarelli MA; Basadonna GP; Friedman AL; Lorber KM; Howe JG; Crouch J; Bia MJ; Kliger AS; Lorber MI
    Transplantation; 1997 Sep; 64(6):848-52. PubMed ID: 9326409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High incidence of post transplant lymphoproliferative disorder after antithymocyte globulin-based conditioning and ineffective prediction by day 28 EBV-specific T lymphocyte counts.
    Hoegh-Petersen M; Goodyear D; Geddes MN; Liu S; Ugarte-Torres A; Liu Y; Walker JT; Fonseca K; Daly A; Duggan P; Stewart D; Russell JA; Storek J
    Bone Marrow Transplant; 2011 Aug; 46(8):1104-12. PubMed ID: 21057556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.